Health

  • January 07, 2026

    Fla. Notice To Medicaid Enrollees Is Inadequate, Judge Says

    A Florida federal judge has found that the state's notices to residents cutting their Medicaid coverage "border on the incomprehensible" and violate the residents' due process by depriving them of a chance to challenge the decision.

  • January 07, 2026

    Ga. Health Clinic, Ex-Aide Reach Deal In Wage Fight

    A Georgia mental health clinic and a former aide have reached a tentative agreement that, if approved, would end the ex-aide's suit alleging she was forced to resign last year after the clinic refused to hand over thousands in unpaid overtime.

  • January 07, 2026

    New Mexico Nursing Facility Files Ch. 11

    The operator of a 369-bed skilled nursing facility in Albuquerque, New Mexico, has filed for Chapter 11 protection in a Florida bankruptcy court with more than $1 million in debt and has been granted joint administration with its already-bankrupt management affiliate.

  • January 07, 2026

    Potomac Law Adds Former DOJ, HHS Civil Rights Atty

    Potomac Law Group has hired a healthcare attorney with over 15 years working on LGBTQ+ protections and other civil rights issues at the Justice Department and the Department of Health and Human Services.

  • January 07, 2026

    Healthpeak Tees Up IPO Plans For Senior Housing REIT

    Healthpeak Properties Inc. said Wednesday it submitted plans to regulators for the formation of a real estate investment trust dedicated to senior housing and the launching of an initial public offering for the company.

  • January 07, 2026

    Firm In 'Maya' Verdict Seeks Coverage For Spinoff Fee Row

    The firm that secured a $213 million award in favor of Maya Kowalski, the person at the center of the Netflix documentary "Take Care of Maya," told a Florida federal court that its professional liability insurer owed coverage for a spinoff suit involving trial consultant fees. 

  • January 07, 2026

    Detroit Pension Fund Wins 'Close' Call To Lead Investor Suit

    A Detroit pension fund should lead a proposed shareholder class action against MoonLake Immunotherapeutics, though a competing bid by a France-based lab worker and screenwriter alleges a "marginally larger" investment loss, a Manhattan federal judge has determined.

  • January 07, 2026

    Covenant Health Sued Over Patient Data Security Breach

    Nonprofit healthcare system Covenant Health Inc. has been hit with a proposed class action over a data breach that reportedly compromised the information of nearly half a million people.

  • January 07, 2026

    FDA Pushes Back On Vape Cos.' 5th Circ. Appeal

    The U.S. Food and Drug Administration is urging the Fifth Circuit to reject a group of appeals from e-cigarette manufacturers seeking to overturn the marketing denial of their flavored vapes, saying the agency did not abuse its discretion in rejecting the companies' products.

  • January 06, 2026

    8th Circ. Revives Jail Suicide Suit Against Mental Health Org.

    An Eighth Circuit panel unanimously revived a lawsuit Tuesday by the family of an Iowa jail inmate who died by suicide, holding that a jury could find that a mental health provider's alleged incomplete report to jail staff put the inmate at greater risk.  

  • January 06, 2026

    Judge Hints Conn. Dentist's Press Release Claims Lack Teeth

    A Connecticut appellate judge seemed to doubt Tuesday that a dentist had asserted clear constitutional claims against state officials who issued a press release about his $300,000 False Claims Act settlement, suggesting the case might actually sound in defamation.

  • January 06, 2026

    Bankrupt Hospital Wants Out Of $3B BCBS Antitrust Deal

    A bankrupt Alabama hospital is asking a federal judge to allow it to drop out of a $2.8 billion antitrust class action settlement with Blue Cross Blue Shield, saying it may be forced to shut down unless it can pursue separate relief in bankruptcy court.

  • January 06, 2026

    Cigna Accused Of Rigging Market For Life-Saving Drugs

    Patients with chronic health conditions sued Cigna in an Illinois federal court alleging in a proposed class action Tuesday that the company and its pharmacy and pharmacy benefit manager subsidiaries use exclusive agreements to lock users into a network where Byzantine refill processes have been deliberately erected to limit payouts for life-saving drugs.

  • January 06, 2026

    FTC Signals Support Of Miss. Bill For Midwives' Solo Practice

    A Federal Trade Commission official on Monday encouraged a Mississippi lawmaker to keep in mind the possible motives of opponents of proposed legislation that would exempt midwives from having to contract with physicians to provide advanced-level nursing care.

  • January 06, 2026

    FDA To Ease Regulation Of Wearables, Decision Software

    U.S. Food and Drug Administration Commissioner Marty Makary touted new federal guidance on Tuesday that he said would promote innovation by making it easier to bring certain kinds of wearable devices and clinical-decision software to market without a strict regulatory review.

  • January 06, 2026

    GAO IDs 4 Funding Programs As Lacking Fraud Controls

    The U.S. Government Accountability Office has identified four federal agency funding programs as having failed to incorporate certain key requirements and leading practices meant to oversee and prevent fraud, waste and abuse in awards. 

  • January 06, 2026

    Ramey Blocked As Atty In Image Patent Fight In NY

    Intellectual property attorney William Ramey was prevented from representing the owner of image processing and modifying patents used in special eyeglasses in an infringement suit in New York federal court, leading the company to abandon the case.

  • January 06, 2026

    1st Circ. Questions Feds' Mootness Claim In NIH Grant Suits

    The First Circuit appeared to push back Tuesday on assertions by the government that new guidance for terminating medical research grants over supposed links to issues like DEI, gender identity and vaccines — along with a partial settlement last week — moot a pair of lawsuits challenging the directives.

  • January 06, 2026

    7th Circ. Blocks Satanic Temple's Ind. Abortion Law Challenge

    The Seventh Circuit ruled Tuesday the Satanic Temple doesn't have standing to challenge Indiana's abortion ban, saying it has no ties to an in-person abortion clinic in the state and that its argument it could be prosecuted for providing telehealth appointments to those seeking the procedure isn't enough to show injury.

  • January 06, 2026

    3rd Circ. Backs DOL In Home Healthcare Wage Case

    The Third Circuit upheld a $1 million judgment against home health company WiCare Home Care Agency LLC Tuesday, finding it was within the secretary of labor's power to write regulations keeping "third-party employers" subject to the Fair Labor Standards Act and not exempt under a provision for "companionship services."

  • January 06, 2026

    RFK Jr. Can't Avoid Medical Groups' Challenge To Vax Policy

    A Boston federal judge on Tuesday rebuffed U.S. Health and Human Services Secretary Robert F. Kennedy Jr.'s bid to dismiss a challenge to vaccine policy changes, saying medical associations have plausibly alleged a federal vaccine committee is not fairly balanced.

  • January 06, 2026

    NYC Hospital Network, Co. Fight Class Cert. In Wage Suit

    NYC Health and Hospitals workers weren't subject to a single policy that violated federal law, the hospital network and a staffing company told a New York federal court, urging it to reject the workers' bid for collective certification in their wage suit.

  • January 06, 2026

    Public Health Atty Talks Botulism, Infants And FDA Staffing

    Three years ago, a bacterial outbreak at a Michigan manufacturing plant sparked a shutdown and a national infant formula shortage. Another episode last year at a formula plant in Iowa should be a red flag for the public and a short-handed FDA, according to Sarah Sorscher of the Center for Science in the Public Interest.

  • January 06, 2026

    Drugmakers Fight Multifront Legal Battles Over GLP-1s

    In the wake of U.S. Food and Drug Administration approvals for GLP-1 weight-loss drugs, surging public demand and massive profits have inspired a broad range of drugmaker litigation against competitors, alleged counterfeits and telehealth providers.

  • January 06, 2026

    Wyo. High Court Strikes Down 2 Laws Restricting Abortion

    The Wyoming Supreme Court struck down the state's near-total abortion ban and a first-of-its-kind prohibition on abortion pills on Tuesday, saying the laws violated the state constitution.

Expert Analysis

  • SDNY OpenAI Order Clarifies Preservation Standards For AI

    Author Photo

    The Southern District of New York’s recent order in the OpenAI copyright infringement litigation, denying discovery of The New York Times' artificial intelligence technology use, clarifies that traditional preservation benchmarks apply to AI content, relieving organizations from using a “keep everything” approach, says Philip Favro at Favro Law.

  • 4 Strategies To Ensure Courts Calculate Restitution Correctly

    Author Photo

    Recent reversals of restitution orders across the federal appeals courts indicate that some lower courts are misapplying fundamental restitution principles, so defense attorneys should consider a few ways to vigilantly press these issues with the sentencing judge, says Wesley Gorman at Comber Miller.

  • Assessing The Future Of The HIPAA Reproductive Health Rule

    Author Photo

    In light of a Texas federal court's recent decision to strike down a U.S. Department of Health and Human Services rule aimed to protect the privacy of patients seeking abortions and gender-affirming care, entities are at least temporarily relieved from compliance obligations, but tensions are likely to continue for the foreseeable future, says Liz Heddleston at Woods Rogers.

  • Opinion

    Expert Reports Can't Replace Facts In Securities Fraud Cases

    Author Photo

    The Ninth Circuit's 2023 decision in Nvidia v. Ohman Fonder — and the U.S. Supreme Court's punt on the case in 2024 — could invite the meritless securities litigation the Private Securities Litigation Reform Act was designed to prevent by substituting expert opinions for facts to substantiate complaint assertions, say attorneys at A&O Shearman.

  • Opinion

    High Court, Not A Single Justice, Should Decide On Recusal

    Author Photo

    As public trust in the U.S. Supreme Court continues to decline, the court should adopt a collegial framework in which all justices decide questions of recusal together — a reform that respects both judicial independence and due process for litigants, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.

  • Series

    Traveling Solo Makes Me A Better Lawyer

    Author Photo

    Traveling by myself has taught me to assess risk, understand tone and stay calm in high-pressure situations, which are not only useful life skills, but the foundation of how I support my clients, says Lacey Gutierrez at Group Five Legal.

  • Opinion

    DOJ's Tracing Rule For Pandemic Loan Fraud Is Untenable

    Author Photo

    In conducting investigations related to COVID-19 relief fraud, the government's assertion that loan proceeds are nonfungible and had to have been segregated from other funds is unsupported by underlying legislation, precedent or the language establishing similar federal relief programs, say Sharon McCarthy, Jay Nanavati and Lasya Ravulapati at Kostelanetz.

  • New Health AI Guidance Features A Provider-Centric Approach

    Author Photo

    New guidance from the Joint Commission and Coalition for Health AI regarding the responsible use of artificial intelligence in healthcare deviates from preexisting guidance by recommending a comprehensive framework for using AI tools, focusing on healthcare provider organizations rather than on AI developers, say attorneys at Ropes & Gray.

  • Series

    Law School's Missed Lessons: Client Service

    Author Photo

    Law school teaches you how to interpret the law, but it doesn't teach you some of the key ways to keeping clients satisfied, lessons that I've learned in the most unexpected of places: a book on how to be a butler, says Gregory Ramos at Armstrong Teasdale.

  • How Occasional Activists Have Reshaped Proxy Fights

    Author Photo

    The sophistication and breadth of first-time activist engagement continue to shape corporate governance and strategic outcomes, as evidenced across corporate annual meetings this summer, meaning advisers should anticipate continued innovation in tactics, increased regulatory complexity, and a persistent focus on board accountability, say attorneys at MoFo.

  • Bid Protest Spotlight: Documentation, Overrides, Eligibility

    Author Photo

    Recent decisions by the U.S. Court of Federal Claims and the U.S. Government Accountability Office illustrate the importance of contemporaneous documentation in proposal evaluations, the standards for an agency’s override of a Competition in Contracting Act stay, and the regulatory requirements for small business joint ventures, says Cody Fisher at MoFo.

  • Shutdown Imperils Telehealth Access For Medicare Patients

    Author Photo

    The federal government shutdown that commenced on Oct. 1 coincided with the expiration of certain telehealth flexibilities that had preserved expansive access to telehealth services for Medicare beneficiaries following COVID-19, creating significant legal and financial uncertainty for healthcare providers and patients, say attorneys at Robinson & Cole.

  • Mass. Ruling May Pave New Avenue To Target Subpoenas

    Author Photo

    A Massachusetts federal court’s recent decision to quash a subpoena seeking information on gender-affirming care at Boston Children’s Hospital is a significant departure from courts' deferential approach to subpoena enforcement, and may open a new pathway for practitioners challenging investigative tools in the future, say attorneys at Gibson Dunn.

  • What To Expect After FDA Warnings To GLP-1 Compounders

    Author Photo

    The U.S. Food and Drug Administration's recent warning letters to companies advertising compounded versions of GLP-1 medications raise questions not just about the enforcement outlook for marketing such products, but also about the future of drug compounding as a whole, say attorneys at Spencer Fane.

  • Why Justices Seem Inclined To Curtail Del. Affidavit Statute

    Author Photo

    After recent oral argument before the U.S. Supreme Court in Berk v. Choy — asking whether Delaware's affidavit-of-merit statute applies in federal diversity actions, or whether the Federal Rules of Civil Procedure displace the state requirement — it appears the court is poised to simplify the standard approach, says Eric Weitz of The Weitz Law Firm.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.